Objective: Atrial Fibrillation (AF) and chronic kidney disease frequently coexist in the elderly. Warfarin-like drugs (WLDs) may be associated with a relatively greater decrease of estimated glomerular filtration rate (eGFR) as compared to direct oral anticoagulants (DOACs), but there is no evidence on the medium- and long-term changes. To further elucidate this issue in elderly patients with AF, we investigated the renal function deterioration in the two groups of the study (DOACs or WLDs). Patients and Methods: A total of 420 AF patients were enrolled (mean age: 77.0 ± 6.0 years; 136 on WLDs and 284 on DOACs). These patients underwent three eGFR measurements during the follow-up period. The between-arms difference of eGFR decline over time was investigated by Linear Mixed Models and group-based trajectory model analyses. Results: In the whole study cohort, after a median follow-up of 4.9 years (interquartile range: 2.7-7.0 years), eGFR decreased from 67.4 ± 18.2 to 47.1 ± 14.3 mL/min/1.73 m2 (p < 0.001). Remarkably, patients on DOACs experienced a significantly smaller eGFR decline than WLDs patients (-21.3% vs. -45.1%, p < 0.001) and this was true both in the medium-term (-6.6 vs. -19.9 mL/min/1.73 m2) and in the long-term (-13.5 versus -34.2 mL/min/1.73 m2) period. After stratification into five subgroups according to trajectories of renal function decline over time, logistic regression showed that DOACs patients had from 3.03 to 4.24-fold greater likelihood to belong to the trajectory with less marked eGFR decline over time than WLDs patients. Conclusion: Elderly patients with AF on treatment with DOACs had a relatively smaller decline of eGFR over time compared to those on treatment with WLDs. This is consistent with what was partly reported in the literature.

Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation / Armentaro, Giuseppe; D'Arrigo, Graziella; Bo, Mario; Cassano, Velia; Miceli, Sofia; Pitino, Annalisa; Tripepi, Giovanni; Romeo, Santina Maria Grazia; Sesti, Giorgio; Lip, Gregory Y H; Pastori, Daniele; Gori, Mercedes; Sciacqua, Angela. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - 14:(2023), pp. 1-10. [10.3389/fphar.2023.1210560]

Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation

Sesti, Giorgio
Supervision
;
Pastori, Daniele;
2023

Abstract

Objective: Atrial Fibrillation (AF) and chronic kidney disease frequently coexist in the elderly. Warfarin-like drugs (WLDs) may be associated with a relatively greater decrease of estimated glomerular filtration rate (eGFR) as compared to direct oral anticoagulants (DOACs), but there is no evidence on the medium- and long-term changes. To further elucidate this issue in elderly patients with AF, we investigated the renal function deterioration in the two groups of the study (DOACs or WLDs). Patients and Methods: A total of 420 AF patients were enrolled (mean age: 77.0 ± 6.0 years; 136 on WLDs and 284 on DOACs). These patients underwent three eGFR measurements during the follow-up period. The between-arms difference of eGFR decline over time was investigated by Linear Mixed Models and group-based trajectory model analyses. Results: In the whole study cohort, after a median follow-up of 4.9 years (interquartile range: 2.7-7.0 years), eGFR decreased from 67.4 ± 18.2 to 47.1 ± 14.3 mL/min/1.73 m2 (p < 0.001). Remarkably, patients on DOACs experienced a significantly smaller eGFR decline than WLDs patients (-21.3% vs. -45.1%, p < 0.001) and this was true both in the medium-term (-6.6 vs. -19.9 mL/min/1.73 m2) and in the long-term (-13.5 versus -34.2 mL/min/1.73 m2) period. After stratification into five subgroups according to trajectories of renal function decline over time, logistic regression showed that DOACs patients had from 3.03 to 4.24-fold greater likelihood to belong to the trajectory with less marked eGFR decline over time than WLDs patients. Conclusion: Elderly patients with AF on treatment with DOACs had a relatively smaller decline of eGFR over time compared to those on treatment with WLDs. This is consistent with what was partly reported in the literature.
2023
doacs; egfr decline; atrial fibrillation; chronic kidney disease; elderly; warfarin-like drugs
01 Pubblicazione su rivista::01a Articolo in rivista
Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation / Armentaro, Giuseppe; D'Arrigo, Graziella; Bo, Mario; Cassano, Velia; Miceli, Sofia; Pitino, Annalisa; Tripepi, Giovanni; Romeo, Santina Maria Grazia; Sesti, Giorgio; Lip, Gregory Y H; Pastori, Daniele; Gori, Mercedes; Sciacqua, Angela. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - 14:(2023), pp. 1-10. [10.3389/fphar.2023.1210560]
File allegati a questo prodotto
File Dimensione Formato  
Armentaro_Medium-term-and-long-term-renal-function-changes_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 975.27 kB
Formato Adobe PDF
975.27 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1685287
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact